
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
RxERP, a provider of pharmaceutical supply chain infrastructure, announced the release of an upgrade to its flagship serialized ERP and pharmaceutical inventory management platform. The release introduces infrastructure-grade capabilities that transform RxERP from a strong, compliance-ready system into a foundation layer for the modern pharmaceutical supply chain.
"The release of RxERP Hub creates the sources of truth the pharma supply chain has been missing," Steve Madsen, CEO, RxERP said.
The Hub adds unit-level audit logging, enabling every serialized interaction to be tracked, verified, and reviewed. The result is a system that supports compliant operation by default, strengthens investigation readiness, and sets the foundation for a broader pharma ecosystem-focused solution set, including validation, intelligence and automation layers that depend on trusted, structured transaction data.
What’s new
- Serialized audit trail, by default: Every interaction tied to a unit-level serial number is automatically tracked and logged.
- Infrastructure-grade audit logging: Designed to support oversight, investigation readiness, and compliance workflows.
- Built-in sources of truth: Transactions are processed on verified rails, not stitched together after the fact.
- Automated transaction guardrails: Standardizes how serialized events are captured and processed, reducing variability and errors.
Why it matters
- Proof, not assumptions: Streamlined verification of what happened to a product, where, and when.
- Faster risk identification and mitigation: Patterns and anomalies surface more quickly, enabling earlier intervention.
- Reduced operational drag: Fewer exceptions, less manual reconciliation, and clearer accountability
- Operationalized compliance: Audit readiness becomes a part of daily operations, not a scramble
- Better economics and patient outcomes: Reducing waste, preventing costly errors, and supports stronger oversight across taxpayer-funded programs and the broader supply chain
"We built our business on DSCSA compliance with RxERP at the core," said Kody Halcomb, CEO, Independent Pharmaceutical. "Their deep knowledge and understanding of pharma deliver the real-time, unit-level audit trail that lets us stand behind every transaction we touch."
“The release of RxERP “Hub” creates the sources of truth the pharma supply chain has been missing,” Steve Madsen said. “We built the guardrails and automated the road where pharmaceutical transactions are processed. The results are infrastructure that logs every interaction in a serialized audit trail, unit-level proof that becomes operational across the ecosystem, and teams that can act with greater confidence and efficiency.”



















